Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata New Fragrance

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00370162

Enrollment

Registered

2006-08-30

Start date

2006-06-30

Completion date

Unknown

Last updated

2008-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hygiene

Brief summary

The purpose of this study is to demonstrate the safety of the gynaecological formulation in normal and usual usage condition.

Interventions

DRUGlactoserum

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Integral skin in the tested region

Exclusion criteria

* Pregnancy or breastfeeding women * Use of antiinflammatory or immunosuppression drugs * Topical medication use at the tested region * Active cutaneous gynaecological disease * Personal history of allergic disease at the area to be treated * Allergic or atopic history

Design outcomes

Primary

Measure	Time frame
Adverse Events and its association with the drug in study	—

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026